Mathieu Uzzan

机构：Cliniques Universitaires Saint-Luc, Tel Aviv University, Université Paris-Est Créteil, Paris-Est Sup, Centre Hospitalier Universitaire Henri-Mondor, Assistance Publique – Hôpitaux de Paris, Fédération Hospitalo-Universitaire, Paris Center for Microbiome Medicine, Hôpitaux Universitaires Henri-Mondor, Institut Mondor de Recherche Biomédicale · ORCID：0000-0002-7761-2879

发表论文 191 篇 · 总被引 5433 次 · h-index 31

代表论文

• ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1 (2025 · Journal of Crohn s and Colitis · 被引 123)
• ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 2 (2025 · Journal of Crohn s and Colitis · 被引 51)
• Janus Kinase Inhibitor-Induced Acne in Inflammatory Bowel Disease: An International, Multicenter, Retrospective Cohort Study (2025 · Clinical Gastroenterology and Hepatology · 被引 22)
• Comparative Effectiveness of Tofacitinib vs Upadacitinib for the Treatment of Acute Severe Ulcerative Colitis (2025 · Clinical Gastroenterology and Hepatology · 被引 12)
• Primary intestinal lymphangiectasia: French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins) (2025 · Orphanet Journal of Rare Diseases · 被引 8)
• One‐Year Effectiveness of Upadacitinib in Perianal Crohn's Disease: A Real‐World GETAID Study (2026 · Alimentary Pharmacology & Therapeutics · 被引 6)